Skip to main content
Watch Insiders
RXRX filings

Corporate insider profile

Christopher Gibson Filing Activity

Latest reported as Corporate insider of RECURSION PHARMACEUTICALS, INC. (RXRX).

Purchase filings
0
Reported companies
1
Net open-market value
-$547,200.00
Latest transaction
Jun 5, 2026

Affiliated corporations

Reported company relationships

RXRXLatest reported

RECURSION PHARMACEUTICALS, INC.

Corporate insider

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 5, 2026RECURSION PHARMACEUTICALS, INC. (RXRX)Corporate insiderSale40,000$3.62$144,800
May 22, 2026RECURSION PHARMACEUTICALS, INC. (RXRX)Corporate insiderSale40,000$3.08$123,200
May 7, 2026RECURSION PHARMACEUTICALS, INC. (RXRX)Corporate insiderSale40,000$3.37$134,800
Subscribe to see more data